Demographic, clinical, and scintigraphic comparison of patients affected by palmoplantar pustulosis and severe acne: a retrospective study
Sign Up to like & getrecommendations! Published in 2020 at "Clinical Rheumatology"
DOI: 10.1007/s10067-019-04904-8
Abstract: Objective Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome encompasses heterogeneous dermatological manifestations, mainly palmoplantar pustulosis (PPP) and severe acne (SA). This study aims to explore the necessity of stratified management according to skin lesions.… read more here.
Keywords: clinical scintigraphic; demographic clinical; severe acne; palmoplantar pustulosis ... See more keywords
A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects with Palmoplantar Pustulosis
Sign Up to like & getrecommendations! Published in 2021 at "Dermatology and Therapy"
DOI: 10.1007/s13555-021-00632-7
Abstract: Palmoplantar pustulosis (PPP) is a chronic inflammatory skin condition with neutrophilic infiltration of the epidermis. RIST4721 antagonizes CXC chemokine receptor type 2, which is important in neutrophil recruitment and migration. In this study, the efficacy… read more here.
Keywords: palmoplantar pustulosis; study; efficacy; placebo ... See more keywords
Clinical characteristics and associations of palmoplantar pustulosis: an observational study☆☆☆
Sign Up to like & getrecommendations! Published in 2019 at "Anais Brasileiros de Dermatologia"
DOI: 10.1016/j.abd.2019.04.008
Abstract: BACKGROUND Palmoplantar pustulosis is a chronic and relapsing disease of the palms and soles, which is characterized by scattered clusters of pinhead-sized, sterile pustules. OBJECTIVE The aim of the present study was to determine demographic… read more here.
Keywords: pustulosis; palmoplantar pustulosis; study; history ... See more keywords
Combination biologic therapy for the treatment of severe palmoplantar pustulosis
Sign Up to like & getrecommendations! Published in 2017 at "JAAD Case Reports"
DOI: 10.1016/j.jdcr.2017.03.002
Abstract: IL: interleukin INTRODUCTION Psoriasis is a common chronic disease andmay be the most prevalent autoimmune disease. The estimated prevalence is 2% to 4% of the global population. Fortunately, providers have a plethora of medications to… read more here.
Keywords: treatment; combination biologic; palmoplantar; palmoplantar pustulosis ... See more keywords
Amicrobial pustulosis of the folds and palmoplantar pustulosis simultaneously induced by different tumor necrosis factor-α inhibitors: Demonstration of a shared pathophysiology
Sign Up to like & getrecommendations! Published in 2017 at "JAAD Case Reports"
DOI: 10.1016/j.jdcr.2017.06.003
Abstract: Amicrobial pustulosis of the folds (APF) and palmoplantar pustulosis (PPP) are 2 rare autoinflammatory neutrophilic dermatoses. Many studies report PPP triggered by treatment of inflammatory bowel disease (IBD) with tumor necrosis factor-α (TNF-α) blockers.1, 2… read more here.
Keywords: pustulosis; amicrobial pustulosis; palmoplantar pustulosis; pustulosis folds ... See more keywords
Interventions for chronic palmoplantar pustulosis: abridged Cochrane systematic review and GRADE assessments
Sign Up to like & getrecommendations! Published in 2020 at "British Journal of Dermatology"
DOI: 10.1111/bjd.19560
Abstract: Palmoplantar pustulosis (PPP) is a chronic inflammatory disease in which sterile and relapsing pustules appear on the palms and soles. read more here.
Keywords: palmoplantar; palmoplantar pustulosis; interventions chronic; pustulosis abridged ... See more keywords
Successful therapy of palmoplantar pustulosis with tofacitinib—Report on three cases
Sign Up to like & getrecommendations! Published in 2020 at "Dermatologic Therapy"
DOI: 10.1111/dth.13753
Abstract: Dear Editor, Palmoplantar pustulosis (PPP) is a rare disease affecting the palmoplantar regions characterized by sterile pustules mostly on erythematous ground. The Janus kinase (JAK) inhibitor tofacitinib has been approved for ulcerative colitis, rheumatoid arthritis… read more here.
Keywords: therapy; tofacitinib; ppp; palmoplantar pustulosis ... See more keywords
Successful treatment of secukinumab‐resistant palmoplantar pustulosis by Dupilumab: A case report
Sign Up to like & getrecommendations! Published in 2022 at "Dermatologic Therapy"
DOI: 10.1111/dth.15781
Abstract: Palmoplantar pustulosis (PPP) is a chronic inflammatory skin disease characterized by erythema, scales, and sterile pustules on the palms and soles. 1 Recent studies have focused on the importance of inter-leukin (IL)-17 and IL-36 pathways… read more here.
Keywords: secukinumab resistant; treatment; dupilumab; palmoplantar pustulosis ... See more keywords
Biologic therapies associated with development of palmoplantar pustulosis and palmoplantar pustular psoriasis: a systematic review
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Dermatology"
DOI: 10.1111/ijd.16064
Abstract: Palmoplantar pustulosis (PPP) and palmoplantar pustular psoriasis (PPPP) are chronic inflammatory skin conditions characterized by eruptions of sterile pustules on the palms and/or soles. Biologic use has been associated with PPP and PPPP development in… read more here.
Keywords: pustular psoriasis; palmoplantar pustulosis; palmoplantar; palmoplantar pustular ... See more keywords
Palmoplantar pustulosis and acrodermatitis continua of Hallopeau: demographic and clinical comparative study in a large multicentre cohort
Sign Up to like & getrecommendations! Published in 2022 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.18127
Abstract: Acral pustular disease within the pustular psoriasis/psoriasis‐like spectrum mainly includes palmoplantar pustulosis (PPP) and acrodermatitis continua of Hallopeau (ACH). Scarce data argue for a distinction between these two entities, but no study has compared the… read more here.
Keywords: acrodermatitis continua; palmoplantar pustulosis; continua hallopeau;
FRI0707 Drug levels and antidrug antibodies in the development of paradoxical psoriasis and palmoplantar pustulosis
Sign Up to like & getrecommendations! Published in 2017 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2017-eular.3635
Abstract: Background The pathogenesis of psoriasis and palmoplantar pustulosis induced by Tumor Necrosis Factor inhibitors (TNFi) is largely unknown. Only one study, in 9 inflammatory bowel disease patients, investigated the relation with infliximab drug levels in… read more here.
Keywords: drug; psoriasis; drug levels; palmoplantar pustulosis ... See more keywords